NCT07196410View on ClinicalTrials.gov

KAN-004 for Immune-Related Diarrhea or Colitis

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
ColitisDiarrhea Caused by Antitumor Drugs
Interventions
BIOLOGICAL

KAN-004

Each dose of KAN-004 contains a consortium of bacteria isolated from the stool of healthy donors formulated as a powder in a capsule intended for oral administration

Trial Locations (1)

H2X 0A9

Centre Hospitalier de l'Universite de Montreal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER